临沧输卵管通而不畅做通水-【临沧云洲医院】,临沧云洲医院,临沧备孕前应检查哪些项目,临沧试纸一深一浅怀孕可能,临沧检查输卵管需多少钱,临沧女性妇科健康,临沧尿急尿频看什么科,临沧盆腔炎和附件炎的治疗

BEIJING, Feb. 20 (Xinhua) -- Chinese Vice Premier Wang Qishan on Sunday called for sound and fast development of the nation's tourism industry as he called it a strategic pillar of the national economy.The tourism industry has huge potential, which needs further opening up, reform and innovation. Market should play a fundamental role in allocating the resources, Wang told a meeting of tourism work.He stressed the diversified needs of customers should be met, and the market order should be standardized to protect customer's legitimate rights."Local authorities should work together to make tourism a strategic pillar industry," he said.Wang also noted tour guide forces play a very important role in the industry development.More training should be arranged in the areas of professional skills and ethics, as well as response to emergencies.The wage and social security system of the work force should also be improved, he said.
BEIJING, May 24 (Xinhuanet) -- The PlayStation Network's shutdown caused by hacker's attack has cost Sony 14 billion Japanese yen, or 171 million U.S. dollars.Sony revealed the figure on Monday as a part of its overall loss in the massive earthquake and tsunami, 3.2 billion U.S. dollars, in the company's fiscal year ending on March 31, 2011.The 171 million U.S. dollars cover the lost revenue, the customer compensations, the security and legal enhancement fees and the free games the company offered as a goodwill gesture.The cyber-attacks, which kept the PlayStation Network offline from April 20 to May 15, involved the theft of personal data from more than 100 million accounts of the gamers.But the crisis was far from over yet."So far, we have not received any confirmed reports of customer identity theft issues, nor confirmed any misuse of credit cards from the cyber-attack," the company said, "Those are key variables, and if that changes, the costs could change."

BEIJING, Feb. 5 (Xinhua) -- Despite profound changes in the global economy, China's banking industry expects steady growth during the 12th Five-Year Plan (2011-2015), a senior banker said Saturday.China's steady and relatively fast economic growth is expected to lay a solid basis for the development of the commercial banks' main businesses, said Hu Huaibang, chairman of Bank of Communications, the fifth-largest lender.Meanwhile, the transformation of China's economic growth pattern would provide an impetus to the adjustment and optimization of the lenders' businesses, Hu said.Hu predicted businesses, such as consumer credit, asset management and credit cards, would enter a golden era over the next few years, along with the economy's shift to a domestic consumption-driven model from the current export-oriented growth pattern.Also, increases in personal wealth and growing numbers in the middle class would bring huge potential customers and development opportunities to the lenders, Hu said.Further, he urged Chinese banks to improve their services and launch new products to meet diversified demands.
BEIJING, March 8 (Xinhuanet) -- U.S. Food and Drug Administration (FDA) announced there was no new reason for safety concern in Pfizer Inc's Prevenar and Sanofi Aventis SA's ActHIBor vaccines, according to media reports Tuesday.Health agencies "have not detected new safety concerns or unusual reporting patterns" in the vaccines, which are used to prevent forms of meningitis and pneumonia, FDA spokeswoman Shelly Burgess said in an emailed statement.Health agencies in the United States will continue to monitor the vaccines for safety, the spokeswoman added.The Japanese health ministry had decided to suspend the vaccines after four unexplained deaths were reported. The causes of the deaths are still investigated, the Japanese ministry said in a release on its website.
WASHINGTON, March 24 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Thursday approved the use of Zostavax, a live attenuated virus vaccine, for the prevention of shingles in individuals 50 to 59 years of age. Zostavax is already approved for use in individuals 60 years of age and older.In the United States shingles affects approximately 200,000 healthy people between the ages of 50 and 59, per year. It is a disease caused by the varicella-zoster virus, which is a virus in the herpes family and the same virus that causes chickenpox.After an attack of chickenpox, the virus lies dormant in certain nerves in the body. For reasons that are not fully understood, the virus can reappear in the form of shingles, more commonly in people with weakened immune systems and with aging."The likelihood of shingles increases with age. The availability of Zostavax to a younger age group provides an additional opportunity to prevent this often painful and debilitating disease" said Karen Midthun, director of FDA's Center for Biologics Evaluation and Research, in a statement. ( Shingles is characterized by a rash of blisters, which generally develop in a band on one side of the body and can cause severe pain that may last for weeks, and in some people, for months or years after the episode.Approval was based on a multicenter study conducted in the United States and four other countries in approximately 22,000 people who were 50-59 years of age. Half received Zostavax and half received a placebo. Study participants were then monitored for at least one year to see if they developed shingles. Compared with placebo, Zostavax reduced the risk of developing shingles by approximately 70 percent.The most common side effects observed in the study were redness, pain and swelling at the site of injection, and headache, according to the FDA.Zostavax, manufactured by Merck & Co., was originally approved on May 26, 2006, for the prevention of shingles in individuals 60 years of age and older.
来源:资阳报